European Archives - Page 604 of 1121 - European Medical Journal

‘Dry’ Pericarditis with Rapid Progression to Tamponade as a Feature of COVID-19

A 63-year-old female presented to hospital with severe, central, sharp chest pain, exacerbated by deep inspiration and upon lying back. She denied cough, fever, or other systemic symptoms…

EMJ Podcast: Serving Country and Community

Jonathan is joined by Norvell ‘Van’ Coots, President and CEO, Holy Cross Health. Together, they reflect on his start in dermatology, his service in the US military, and the promising rise of telemedicine in bringing patient care closer to home and into the community.

Voluson™ SWIFT: Revolutionising Ultrasound in Healthcare

THE LAUNCH of the state‑of‑the‑art Voluson™ SWIFT (GE Healthcare, Chicago, Illinois, USA) on 29th September 2020 marked a revolutionary progression…

Antihistamine Treatment for Irritable Bowel Syndrome

Irritable bowel syndrome cause many people a lot of pain. A recent research has discovered the biological mechanism for this, so a more efficient treatment.

Intestinal Bacteria Mapped Using Artificial Intelligence

100 BILLION bacteria, approximately, live in our intestines. Medical researchers have so far struggled to study these bacteria in their natural…

Talking to Nancy Globus

Nancy Globus, Vice President for Regulatory and Medicine Safety, Addison Whitney, talks medication safety, product labelling and errors.

Editor's Pick: Giant Cell Arteritis: Navigating Beyond the Headache

Giant cell arteritis (GCA) is an idiopathic granulomatous vasculitis involving medium and large calibre arteries. It is the most common systemic vasculitis, with a female preponderance, and occurs almost exclusively in those >50 years of age…

EMJ Podcast: Lasers and Futuristic Healing

James Carroll explores the clinical applications of laser therapy, his journey into entrepreneurship, and considers what the future of healthcare might look like.

Diarrhoea-Associated Human Adenovirus Structure Mapped for the First Time

HUMAN adenovirus (HAdV) types F40 and F41 are prominent causes of diarrhoea and diarrhoea-associated mortality in more than 50,000 young children worldwide annually. For the first time, researchers have successfully mapped the structure of an enteric HAdV-F41 that may in the long term aid in the treatment for other viral diseases, including coronavirus disease (COVID-19).

The Correlation Between Diet, Illnesses, and the Gut Microbiome

‘HEALTHY’ and plant-based diets promote a microbiome linked to lower risks of common illnesses, such as heart disease, obesity, and Type 2 diabetes mellitus, according to a recent study from epidemiologists and nutritional scientists.